Nathubhai, Amit, Threadgill, M D (2016) New potent and selective tankyrase inhibitors for the treatment of disease or conditions associated with Wnt signalling e.g. colon cancer, prostate cancer, idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease and type-1/type-2 diabetes. WO2017-GB52624.
This is the latest version of this item.
Abstract
Official URL: https://worldwide.espacenet.com/publicationDetails...
| Item Type: | Patents |
|---|---|
| Depositing User: | Amit Nathubhai |
| URI: | https://sure.sunderland.ac.uk/id/eprint/9804 |
Further Details
More Information
Depositing User
Identifiers
Item ID
9804
Identification Number
WO2017-GB52624
Users with ORCIDS
Catalogue record
Date Deposited
10 Aug 2018 13:52
Last Modified
04 Jun 2025 17:29
Contributors
Author
Amit Nathubhai
Author
M.D. Threadgill
University Divisions
Subjects
Available Versions of this Item
-
Use of new and known pyridine or pyrimidine compounds, for the treatment of a disease or condition associated with tankyrase, e.g. cancer selected from e.g. breast, colon, stomach, and liver. (deposited 10 Aug 2018 13:49)
- New potent and selective tankyrase inhibitors for the treatment of disease or conditions associated with Wnt signalling e.g. colon cancer, prostate cancer, idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease and type-1/type-2 diabetes. (deposited 10 Aug 2018 13:52) [Currently Displayed]
Actions (login required)
Altmetric
Altmetric
Altmetric